Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MONOAMINE-OXIDASE-B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 236 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Berlin, I; Anthenelli, RM
      Monoamine oxidases and tobacco smoking

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    2. Kuttab, S; Shang, J; Castagnoli, N
      Rat liver microsomal enzyme catalyzed oxidation of 4-phenyl-trans-1-(2-phenylcyclopropyl)-1,2,3,6-tetrahydropyridine

      BIOORGANIC & MEDICINAL CHEMISTRY
    3. Treseder, SA; Rose, S; Jenner, P
      The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    4. Castagnoli, KP; Steyn, SJ; Petzer, JP; Van der Schyf, CJ; Castagnoli, N
      Neuroprotection in the MPTP parkinsonian C57BL/6 mouse model by a compoundisolated from tobacco

      CHEMICAL RESEARCH IN TOXICOLOGY
    5. Ernst, M; Moolchan, ET; Robinson, ML
      Behavioral and neural consequences of prenatal exposure to nicotine

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    6. Guo, M; Chen, SD; Liu, ZG; Chen, HZ
      Eldepryl prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral neuronal apoptosis in mice

      CHINESE MEDICAL JOURNAL
    7. Gasser, T
      Genetics of Parkinson's disease

      JOURNAL OF NEUROLOGY
    8. Brown, RE; Stevens, DR; Haas, HL
      The physiology of brain histamine

      PROGRESS IN NEUROBIOLOGY
    9. Mills, D; Ledger, R
      The effects of oral selegiline hydrochloride on learning and training in the dog: A psychobiological interpretation

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    10. Su, RB; Li, J; Li, X; Qin, BY
      Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine

      ACTA PHARMACOLOGICA SINICA
    11. Han, YN; Choo, Y; Lee, YC; Moon, YI; Kim, SD; Choi, JW
      Monoamine oxidase B inhibitors from the fruits of Opuntia ficus-indica var. saboten

      ARCHIVES OF PHARMACAL RESEARCH
    12. Inazu, M; Takeda, H; Ikoshi, H; Sugiswa, M; Uchida, Y; Matsumiya, T
      Pharmacological characterization and visualization of the glial serotonin transporter

      NEUROCHEMISTRY INTERNATIONAL
    13. Erdem, SS; Yelekci, K
      Computer modeling of oxygen containing heptylamines as monoamine oxidase inactivators

      JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    14. Li, WS; Sayre, LM
      Reaction of amines with N-1,N-10-ethylene-bridged flavinium salts: the first NMR spectroscopic evidence of C-10a tetrahedral amine adducts

      TETRAHEDRON
    15. Wu, RM; Cheng, CW; Chen, KH; Lu, SL; Shen, DE; Ho, YF; Chern, HD
      The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese

      NEUROLOGY
    16. Isin, EM; de Jonge, M; Castagnoli, N
      Studies on synthetic approaches to 1H- and 2H-indazolyl derivatives

      JOURNAL OF ORGANIC CHEMISTRY
    17. Zhou, G; Miura, Y; Shoji, H; Yamada, S; Matsuishi, T
      Platelet monoamine oxidase B and plasma beta-phenylethylamine in Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    18. Lefebvre, H; Compagnon, P; Contesse, V; Delarue, C; Thuillez, C; Vaudry, H; Kuhn, JM
      Production and metabolism of serotonin (5-HT) by the human adrenal cortex:Paracrine stimulation of aldosterone secretion by 5-HT

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    19. White, WH; Gunyuzlu, PL; Toyn, JH
      Saccharomyces cerevisiae is capable of de novo pantothenic acid biosynthesis involving a novel pathway of beta-alanine production from spermine

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Lee, MH; Lin, RD; Shen, LY; Yang, LL; Yen, KY; Hou, WC
      Monoamine oxidase B and free radical scavenging activities of natural flavonoids in Melastoma candidum D. Don

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    21. Callado, LF; Maeztu, AI; Ballesteros, J; Gutierrez, M; Meana, JJ
      Differential [H-3]idazoxan and [H-3]2-(2-benzofuranyl)-2-imidazoline (2-BFI) binding to imidazoline I-2 receptors in human postmortem frontal cortex

      EUROPEAN JOURNAL OF PHARMACOLOGY
    22. Banchelli, G; Ghelardini, C; Raimondi, L; Galeotti, N; Pirisino, R
      Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    23. Raasch, W; Schafer, U; Chun, J; Dominiak, P
      Biological significance of agmatine, an endogenous ligand at imidazoline binding sites

      BRITISH JOURNAL OF PHARMACOLOGY
    24. Youdim, MBH; Gross, A; Finberg, JPM
      Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

      BRITISH JOURNAL OF PHARMACOLOGY
    25. Sastre, M; Guimon, J; Garcia-Sevilla, JA
      Relationships between beta- and alpha(2)-adrenoceptors and G coupling proteins in the human brain: effects of age and suicide

      BRAIN RESEARCH
    26. Muralikrishnan, D; Ebadi, M
      SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

      BRAIN RESEARCH
    27. Vaughan, JR; Davis, MB; Wood, NW
      Genetics of Parkinsonism: a review

      ANNALS OF HUMAN GENETICS
    28. Tanko, JM; Friedline, R; Suleman, NK; Castagnoli, N
      tert-butoxyl as a model for radicals in biological systems: Caveat emptor

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    29. Boomsma, F; van Dijk, J; Bhaggoe, UM; Bouhuizen, AMB; van den Meiracker, AH
      Variation in semicarbazide-sensitive amine oxidase activity in plasma and tissues of mammals

      COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY & ENDOCRINOLOGY
    30. Foley, P; Gerlach, M; Youdim, MBH; Riederer, P
      MAO-B inhibitors: multiple roles in the therapy of neurodegenerative disorders?

      PARKINSONISM & RELATED DISORDERS
    31. Steyn, SJ; Mienie, LJ; Van der Schyf, CJ
      beta-Oxidation of [9,10(n)-H-3]palmitate by human leukocytes: A simple in situ assay to assess mitochondrial toxicity in the presence of toxins

      TOXICOLOGY METHODS
    32. Logan, J; Fowler, JS; Volkow, ND; Wang, GJ; MacGregor, RR; Shea, C
      Reproducibility of repeated measures of deuterium substituted [C-11]L-deprenyl ([C-11]L-deprenyl-D2) binding in the human brain

      NUCLEAR MEDICINE AND BIOLOGY
    33. Goggi, J; Theofilopoulos, S; Riaz, SS; Jauniaux, E; Stern, GM; Bradford, HF
      The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture

      NEUROREPORT
    34. Barrot, M; Rettori, MC; Guardiola-Lemaitre, B; Jarry, C; Le Moal, M; Piazza, PV
      Interactions between imidazoline binding sites and dopamine levels in the rat nucleus accumbens

      EUROPEAN JOURNAL OF NEUROSCIENCE
    35. Gross-Isseroff, R; Weizman, A; Fieldust, SJ; Israeli, M; Biegon, A
      Unaltered alpha(2)-noradrenergic/imidazoline receptors in suicide victims:a postmortem brain autoradiographic analysis

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    36. Bradberry, CW
      Applications of microdialysis methodology in nonhuman primates: Practice and rationale

      CRITICAL REVIEWS IN NEUROBIOLOGY
    37. Patat, A
      Clinical pharmacology of psychotropic drugs

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    38. Ogawa, N
      Factors affecting levodopa effects in Parkinson's disease

      ACTA MEDICA OKAYAMA
    39. Egashira, T; Takayama, F; Sakai, K; Yamanaka, Y
      Styrene inhibits monoamine oxidase A, but not monoamine oxidase B in monkey brain mitochondria

      TOXICOLOGY LETTERS
    40. Rabey, JM; Sagi, I; Huberman, M; Melamed, E; Korczyn, A; Giladi, N; Inzelberg, R; Djaldetti, R; Klein, C; Berecz, G
      Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa

      CLINICAL NEUROPHARMACOLOGY
    41. Mellick, GD; Buchanan, DD; Silburn, PA; Chan, DKY; Le Couteur, DG; Law, LK; Woo, J; Pang, CP
      The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population

      JOURNAL OF NEUROLOGY
    42. Andres, N; Rodriguez, MJ; Andrade, C; Rowe, W; Quirion, R; Mahy, N
      Increase in AMPA receptors in aged memory-impaired rats is not associated with increase in monoamine oxidase B levels

      NEUROSCIENCE
    43. Ballesteros, J; Maeztu, AI; Callado, LF; Gutierrez, M; Garcia-Sevilla, JA; Meana, JJ
      I-2-Imidazoline receptors and monoamine oxidase B enzyme sites in human brain: covariation with age

      NEUROSCIENCE LETTERS
    44. Gotz, ME; Gerstner, A; Harth, R; Dirr, A; Janetzky, B; Kuhn, W; Riederer, P; Gerlach, M
      Altered redox state of platelet coenzyme Q(10) in Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    45. Nicotra, A; Parvez, SH
      Cell death induced by MPTP, a substrate for monoamine oxidase B

      TOXICOLOGY
    46. Boschi, G; Scherrmann, JM
      Microdialysis in mice for drug delivery research

      ADVANCED DRUG DELIVERY REVIEWS
    47. Edmondson, DE; Bhattacharrya, AK; Xu, JJ
      Evidence for alternative binding modes in the interaction of benzylamine analogues with bovine liver monoamine oxidase B

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    48. Hewitt, GW; Somers, JJ; Sieburth, SM
      Synthesis of alpha-alkyl-alpha-aminosilanes by rhodium-catalyzed hydrosilylation of Boc-protected vinyl amines

      TETRAHEDRON LETTERS
    49. Costa-Mallen, P; Costa, LG; Smith-Weller, T; Franklin, GM; Swanson, PD; Checkoway, H
      Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    50. Brizio, C; Otto, A; Brandsch, R; Passarella, S; Barile, M
      A protein factor of rat liver mitochondrial matrix involved in flavinylation of dimethylglycine dehydrogenase

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    51. Sanchez-Blazquez, P; Boronat, MA; Olmos, G; Garcia-Sevilla, JA; Garzon, J
      Activation of I-2-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at thesereceptors

      BRITISH JOURNAL OF PHARMACOLOGY
    52. Piletz, JE; Zhu, H; Ordway, O; Stockmeier, C; Dilly, G; Reis, D; Halaris, A
      Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression

      BIOLOGICAL PSYCHIATRY
    53. Piletz, JE; Halbreich, U
      Imidazoline and alpha(2A)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy

      BIOLOGICAL PSYCHIATRY
    54. Spacey, SD; Wood, NW
      The genetics of Parkinson's disease

      CURRENT OPINION IN NEUROLOGY
    55. Checkoway, H; Nelson, LM
      Epidemiologic approaches to the study of Parkinson's disease etiology

      EPIDEMIOLOGY
    56. Tsopelas, C
      Radiolabelling of 4-iodo-N-(2-morpholinoethyl)benzamide with (NaI)-I-123 and (NaI)-I-125

      NUCLEAR MEDICINE AND BIOLOGY
    57. Mukherjee, J; Yang, ZY; Lew, R
      N-(6-F-18-fluorohexyl)-N-methylpropargylamine: A fluorine-18-labeled monoamine oxidase B inhibitor for potential use in PET studies

      NUCLEAR MEDICINE AND BIOLOGY
    58. Yu, J; Castagnoli, N
      Synthesis and MAO-B substrate properties of 1-methyl-4-heteroaryl-1,2,3,6-tetrahydropyridines

      BIOORGANIC & MEDICINAL CHEMISTRY
    59. Satoh, J; Kuroda, Y
      Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease

      NEUROREPORT
    60. Grunblatt, E; Mandel, S; Berkuzki, T; Youdim, MBH
      Apomorphine protects against MPTP-induced neurotoxicity in mice

      MOVEMENT DISORDERS
    61. Mellick, GD; Buchanan, DD; McCann, SJ; James, KM; Johnson, AG; Davis, DR; Liyou, N; Chan, D; Le Couteur, DG
      Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease

      MOVEMENT DISORDERS
    62. Farsang, C; Kapocsi, J
      Imidazoline receptors: From discovery to antihypertensive therapy (facts and doubts)

      BRAIN RESEARCH BULLETIN
    63. Holschneider, DP; Scremin, OU; Huynh, L; Chen, K; Shih, JC
      Lack of protection from ischemic injury of monoamine oxidase B-deficient mice following middle cerebral artery occlusion

      NEUROSCIENCE LETTERS
    64. Newton, TF; Kalechstein, A; Beckson, M; Bartzokis, G; Bridge, TP; Ling, W
      Effects of selegiline pretreatment on response to experimental cocaine administration

      PSYCHIATRY RESEARCH
    65. Fowler, JS; Volkow, ND; Wang, GJ; Ding, YS; Dewey, SL
      PET and drug research and development

      JOURNAL OF NUCLEAR MEDICINE
    66. Fowler, JS; Volkow, ND; Ding, YS; Wang, GJ; Dewey, S; Fischman, MW; Foltin, R; Hitzemann, R
      Positron emission tomography studies of dopamine-enhancing drugs

      JOURNAL OF CLINICAL PHARMACOLOGY
    67. Maruyama, W; Naoi, M
      Neuroprotection by(-)-deprenyl and related compounds

      MECHANISMS OF AGEING AND DEVELOPMENT
    68. Di Monte, DA; Tokar, I; Langston, JW
      Impaired glutamate clearance as a consequence of energy failure caused by MPP+ in astrocytic cultures

      TOXICOLOGY AND APPLIED PHARMACOLOGY
    69. Mellick, GD; Le Couter, DG
      Parkinson's disease, MAOB, and smoking

      NEUROLOGY
    70. Wiest, SA; Steinberg, MI
      H-3[2-(2-benzofuranyl)-2-imidazoline] (BFI) binding in human platelets: modulation by tranylcypromine

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    71. Kaehler, ST; Philippu, A; Singewald, N
      Effects of local MAO inhibition in the locus coeruleus on extracellular serotonin and 5-HIAA during exposure to sensory and cardiovascular stimuli

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    72. Simon, DK; Standaert, DG
      Neuroprotective therapies

      MEDICAL CLINICS OF NORTH AMERICA
    73. Soto, J; Ulibarri, I; Jauregui, JV; Ballesteros, J; Meana, JJ
      Dissociation between I-2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia

      JOURNAL OF PSYCHIATRIC RESEARCH
    74. Fornai, F; Chen, K; Giorgi, FS; Gesi, M; Alessandri, MG; Shih, JC
      Striatal dopamine metabolism in monoamine oxidase B-deficient mice: A brain dialysis study

      JOURNAL OF NEUROCHEMISTRY
    75. Chen, L; He, M; Sibille, E; Thompson, A; Sarnyai, Z; Baker, H; Shippenberg, T; Toth, M
      Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B

      JOURNAL OF NEUROCHEMISTRY
    76. Vacher, B; Bonnaud, B; Funes, P; Jubault, N; Koek, W; Assie, MB; Cosi, C; Kleven, M
      Novel derivatives of 2-pyridinemethylamine as selective, potent, and orally active agonists at 5-HT1A receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    77. Egashira, T; Takayama, F; Yamanaka, Y
      The inhibition of monoamine oxidase activity by various antidepressants: Differences found in various mammalian species

      JAPANESE JOURNAL OF PHARMACOLOGY
    78. Huang, W; Chen, Y; Shohami, E; Weinstock, M
      Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse

      EUROPEAN JOURNAL OF PHARMACOLOGY
    79. Ortiz-Maldonado, M; Ballou, DP; Massey, V
      Use of free energy relationships to probe the individual steps of hydroxylation of p-hydroxybenzoate hydroxylase: Studies with a series of 8-substituted flavins

      BIOCHEMISTRY
    80. McIntire, WS; Everhart, ET; Craig, JC; Kuusk, V
      A new procedure for deconvolution of inter-/intramolecular intrinsic primary and alpha-secondary deuterium isotope effects from enzyme steady-state kinetic data

      JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
    81. YELEKCI K; SILVERMAN RB
      EFFECT OF THE LOCUS OF THE OXYGEN-ATOM IN AMINO ETHERS ON THE INACTIVATION OF MONOAMINE-OXIDASE-B

      Journal of enzyme inhibition
    82. LEHOUEZEC J
      NICOTINE - ABUSED SUBSTANCE AND THERAPEUTIC AGENT

      Journal of psychiatry & neuroscience
    83. Ilgin, N
      Functional imaging of neurotransmitter systems in movement disorders

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    84. TARIOT PN; GOLDSTEIN B; PODGORSKI CA; COX C; FRAMBES N
      SHORT-TERM ADMINISTRATION OF SELEGILINE FOR MILD-TO-MODERATE DEMENTIAOF THE ALZHEIMERS TYPE

      The American journal of geriatric psychiatry
    85. AKEFELDT A; MANSSON JE
      IS MONOAMINE-OXIDASE ACTIVITY ELEVATED IN PRADER-WILLI-SYNDROME

      European child & adolescent psychiatry
    86. Zhao, ZY; Mabic, S; Kuttab, S; Franot, C; Castagnoli, K; Castagnoli, N
      Rat liver microsomal enzyme catalyzed oxidation of 1-cyclopropyl-4-phenyl-1,2,3,6-tetrahydropyridine

      BIOORGANIC & MEDICINAL CHEMISTRY
    87. MEWIES M; MCINTIRE WS; SCRUTTON NS
      COVALENT ATTACHMENT OF FLAVIN ADENINE-DINUCLEOTIDE (FAD) AND FLAVIN MONONUCLEOTIDE (FMN) TO ENZYMES - THE CURRENT STATE OF AFFAIRS

      Protein science
    88. KNOLL J
      (-)DEPRENYL (SELEGILINE), A CATECHOLAMINERGIC ACTIVITY ENHANCER (CAE)SUBSTANCE ACTING IN THE BRAIN

      Pharmacology & toxicology
    89. Payami, H; Zareparsi, S
      Genetic epidemiology of Parkinson's disease

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    90. HATTORI N; YOSHINO H; TANAKA M; SUZUKI H; MIZUNO Y
      GENOTYPE IN THE 24-KDA SUBUNIT GENE (NDUFV2) OF MITOCHONDRIAL COMPLEX-I AND SUSCEPTIBILITY TO PARKINSON-DISEASE

      Genomics
    91. BANDMANN O; MARSDEN CD; WOOD NW
      GENETIC-ASPECTS OF PARKINSONS-DISEASE

      Movement disorders
    92. RIEDL AG; WATTS PM; JENNER P; MARSDEN CD
      P450 ENZYMES AND PARKINSONS-DISEASE - THE STORY SO FAR

      Movement disorders
    93. NAGARAJA R; JERMAK C; TRUSGNICH M; YOON J; MACMILLAN S; MCCAULEY B; BROWNSTEIN B; SCHLESSINGER D
      YAC STS MAP OF 15 MB OF XP21.3-P11.3, AT 100 KB RESOLUTION, WITH REFINED COMPARISONS OF GENETIC DISTANCES AND DMD STRUCTURE/

      Gene
    94. WOOD NW
      GENETIC RISK-FACTORS IN PARKINSONS-DISEASE

      Annals of neurology
    95. MESZAROS Z; BORCSICZKY D; MATE M; TARCALI J; SZOMBATHY T; TEKES K; MAGYAR K
      PLATELET MAO-B ACTIVITY AND SEROTONIN CONTENT IN PATIENTS WITH DEMENTIA - EFFECT OF AGE, MEDICATION, AND DISEASE

      Neurochemical research
    96. HUSZTI Z
      CARRIER-MEDIATED HIGH-AFFINITY UPTAKE SYSTEM FOR HISTAMINE IN ASTROGLIAL AND CEREBRAL ENDOTHELIAL-CELLS

      Journal of neuroscience research
    97. BUCK A; FREY LD; BLAUENSTEIN P; KRAMER G; SIEGEL A; WEBERS B; SCHUBIGER PA; WIESER HG
      MONOAMINE-OXIDASE-B SINGLE-PHOTON EMISSION TOMOGRAPHY WITH [I-123] RO-43-0463 - IMAGING IN VOLUNTEERS AND PATIENTS WITH TEMPORAL-LOBE EPILEPSY

      European journal of nuclear medicine
    98. BAJAJ NPS; SHAW C; WARNER T; RAYCHAUDHURI K
      THE GENETICS OF PARKINSONS-DISEASE AND PARKINSONIAN SYNDROMES

      Journal of neurology
    99. KHANDWALA H; LOOMIS CW
      MILACEMIDE, A GLYCINE PRO-DRUG, INHIBITS STRYCHNINE-ALLODYNIA WITHOUTAFFECTING NORMAL NOCICEPTION IN THE RAT

      Pain
    100. GARCIASEVILLA JA; ESCRIBA PV; WALZER C; BOURAS C; GUIMON J
      IMIDAZOLINE RECEPTOR PROTEINS IN BRAINS OF PATIENTS WITH ALZHEIMERS-DISEASE

      Neuroscience letters


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 21:41:16